Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGVISOMANT for Brain neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 20 adverse event reports in the FDA FAERS database where PEGVISOMANT was used for Brain neoplasm.

Most Reported Side Effects for PEGVISOMANT

Side Effect Reports % Deaths Hosp.
Off label use 460 15.3% 27 64
Drug ineffective 328 10.9% 2 32
Insulin-like growth factor increased 320 10.6% 2 43
Product dose omission issue 255 8.5% 2 36
Headache 244 8.1% 1 41
Fatigue 224 7.4% 6 38
Arthralgia 184 6.1% 1 31
Death 162 5.4% 162 11
Injection site pain 161 5.3% 1 23
Product use issue 158 5.2% 11 52
Diarrhoea 151 5.0% 1 39
Nausea 142 4.7% 0 45
Pain 121 4.0% 0 22
Malaise 114 3.8% 3 23
Needle issue 110 3.7% 0 18

Other Indications for PEGVISOMANT

Acromegaly (1,911) Gigantism (252) Pituitary tumour (82) Product used for unknown indication (73) Pituitary tumour benign (48) Insulin-like growth factor increased (46) Hypothalamo-pituitary disorder (41) Neoplasm (27) Blood growth hormone increased (21) Insulin-like growth factor abnormal (20)

Other Drugs Used for Brain neoplasm

TEMOZOLOMIDE (286) BEVACIZUMAB (166) PROCARBAZINE (142) ETOPOSIDE (121) CARBOPLATIN (103) VINCRISTINE (93) CYCLOPHOSPHAMIDE (72) CISPLATIN (67) TRAMETINIB DIMETHYL SULFOXIDE (55) BEVACIZUMAB-AWWB (50)

Related Pages

PEGVISOMANT Full Profile All Brain neoplasm Drugs PEGVISOMANT Demographics PEGVISOMANT Timeline